Cargando…
Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
SIMPLE SUMMARY: Anthracycline-induced cardiotoxicity (AIC) poses a significant clinical challenge in the management of cancer patients. Thus, the development of effective preventive measures for AIC is a heavily studied subject in the field of cardio-oncology. A new class of agents, namely angiotens...
Autores principales: | Sobiborowicz-Sadowska, Aleksandra M., Kamińska, Katarzyna, Cudnoch-Jędrzejewska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818213/ https://www.ncbi.nlm.nih.gov/pubmed/36612307 http://dx.doi.org/10.3390/cancers15010312 |
Ejemplares similares
-
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
por: Sobczuk, Paweł, et al.
Publicado: (2020) -
A Review on the Neurotoxic Effects of Doxorubicin
por: Kamińska, Katarzyna, et al.
Publicado: (2023) -
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016) -
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)